Yunfei Yuan Selected Research

Yunfei Yuan Research Topics

Disease

60	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 11/2006
39	Neoplasms (Cancer) 04/2024 - 11/2006
26	Neoplasm Metastasis (Metastasis) 10/2023 - 11/2006
6	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2014
5	Liver Neoplasms (Liver Cancer) 01/2023 - 02/2010
3	Diarrhea 02/2021 - 11/2014
2	Thrombosis (Thrombus) 05/2023 - 11/2019
2	Liver Failure 11/2022 - 04/2013
2	Hypertension (High Blood Pressure) 02/2021 - 08/2020
2	Dehydration (Water Stress) 01/2020 - 08/2015
2	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2005
2	Carcinogenesis 01/2018 - 02/2009
2	Fibrosis (Cirrhosis) 03/2017 - 05/2012
2	Hepatitis B 01/2017 - 07/2015
2	Portal Hypertension 11/2016 - 04/2015
1	Dysbiosis 11/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Alopecia (Baldness) 02/2021
1	Proteinuria 02/2021
1	Fissure in Ano (Anal Fissure) 02/2021
1	Multiple Sclerosis 12/2020
1	Disease Progression 08/2020
1	Inflammation (Inflammations) 01/2020

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 10/2023 - 02/2005
8	MicroRNAs (MicroRNA)IBA 08/2021 - 02/2009
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 11/2006
5	Sorafenib (BAY 43-9006)FDA Link 02/2021 - 02/2016
5	Fetal Proteins (Fetoprotein)IBA 02/2017 - 10/2012
4	Messenger RNA (mRNA)IBA 12/2022 - 06/2011
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2015 - 06/2011
4	Syk KinaseIBA 03/2014 - 02/2005
3	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2017
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2019 - 11/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 11/2014
2	Arginine (L-Arginine)FDA Link 01/2023 - 05/2008
2	Dopamine Receptors (Dopamine Receptor)IBA 12/2022 - 12/2020
2	ElafinIBA 03/2022 - 03/2021
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2022 - 03/2021
2	apatinibIBA 02/2021 - 08/2020
2	Indicators and Reagents (Reagents)IBA 01/2020 - 02/2005
2	Alkenes (Olefins)IBA 01/2020 - 08/2015
2	Conditioned Culture MediaIBA 10/2018 - 06/2018
2	Carcinoembryonic AntigenIBA 01/2017 - 11/2016
2	Angiopoietin-2IBA 12/2016 - 08/2015
2	DNA (Deoxyribonucleic Acid)IBA 04/2016 - 06/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2014 - 05/2012
2	Alanine Transaminase (SGPT)IBA 11/2014 - 05/2012
1	regorafenibIBA 05/2024
1	6-methyladenineIBA 04/2024
1	N-methyladenosineIBA 04/2024
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 10/2023
1	Dopamine D3 ReceptorsIBA 12/2022
1	3,4,4a,10b- tetrahydro- 4- propyl- 2H,5H- (1)benzopyrano(4,3- b)- 1,4- oxazin- 9- olIBA 12/2022
1	IntegrinsIBA 11/2022
1	Ubiquitin-Specific ProteasesIBA 10/2022
1	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 10/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022
1	Nociceptin ReceptorIBA 04/2022
1	Opioid Analgesics (Opioids)IBA 04/2022
1	N- (4- amino- 2- methylquinolin- 6- yl)- 2- (4- ethylphenoxymethyl)benzamideIBA 04/2022
1	nucleoredoxinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	UbiquitinIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	SoilIBA 01/2022
1	Sincalide FDA Link 01/2022
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2022
1	CateninsIBA 01/2022
1	Exonucleases (3' 5' Exonuclease)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	Sodium Channels (Sodium Channel)IBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 12/2020
1	prenylIBA 12/2020
1	SCH 23390IBA 12/2020
1	Dimethyl FumarateIBA 12/2020
1	FumaratesIBA 12/2020
1	Diphosphates (Pyrophosphates)IBA 12/2020
1	Transaminases (Aminotransferases)IBA 08/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 08/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2020
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2020
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2020
1	AmidesIBA 01/2020
1	Local AnestheticsIBA 01/2020
1	Ethiodized Oil (Ethiodol)FDA Link 11/2019
1	cadherin 5IBA 10/2018
1	Delta CateninIBA 10/2018
1	matrigelIBA 06/2018
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2018
1	AgarIBA 01/2018
1	16-iodo-3-methylhexadecanoic acid (MIHA)IBA 01/2018

Therapy/Procedure

13	Therapeutics 02/2024 - 02/2009
13	Hepatectomy 11/2023 - 06/2011
5	Drug Therapy (Chemotherapy) 01/2023 - 06/2012
4	Radiofrequency Ablation 12/2018 - 04/2013
2	Immunotherapy 05/2024 - 05/2023
1	Aftercare (After-Treatment) 10/2022
1	Retreatment 11/2018